L M Schuchter

Author PubWeight™ 29.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999 5.95
2 Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer 2006 4.93
3 American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999 2.03
4 Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer 1997 1.57
5 Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy. Ann Oncol 1999 1.40
6 Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999 1.27
7 Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys 1996 1.14
8 Metastatic melanoma. Curr Treat Options Oncol 2001 1.11
9 Cutaneous manifestations of cancer. Curr Opin Oncol 1999 1.00
10 Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases. J Clin Oncol 1997 0.96
11 Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst 1992 0.92
12 Effects of topical tretinoin on dysplastic nevi. J Clin Oncol 1994 0.91
13 CT of malignant melanoma in the chest, abdomen, and musculoskeletal system. Radiographics 1990 0.87
14 CT of malignant melanoma: patterns of small bowel and mesenteric involvement. J Comput Assist Tomogr 1991 0.86
15 Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy. Med Oncol 1996 0.82
16 Prognostic models in melanoma. Semin Oncol 1997 0.81
17 The role of the pathologist in the diagnosis of melanoma. Curr Opin Oncol 1998 0.78
18 Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination. Med Oncol 1999 0.78
19 Early stage (I, II, III) melanoma. Curr Treat Options Oncol 2001 0.76
20 Melanoma and other skin neoplasms. Curr Opin Oncol 1997 0.76
21 Disseminated melanoma--is there a new standard therapy? N Engl J Med 1992 0.75
22 Melanoma and other skin neoplasms. Curr Opin Oncol 1998 0.75
23 Systemic treatment of metastatic melanoma with chemotherapy. Hematol Oncol Clin North Am 1998 0.75